Stojkovic, Tanya

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology

Myasthenia Gravis and ThymomaPeripheral Neuropathies and Disorders

Cited by 295

Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment

Vermersch, P., de Seze, J., Delisse, B., Lemaire, S., & Stojkovic, T. (2002) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 74

Brain MRI in late‐onset multiple sclerosis

de Seze, J., Delalande, S., Michelin, E., Gauvrit, J. Y., Mackowiak, M. A., Ferriby, D., Stojkovic, T., Defebvre, L., Pruvo, J. P., & Vermersch, P. (2005) · European Journal of Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 31